Comparison of the Virulence-Associated Phenotypes of Five Species of Acinetobacter baumannii Complex |
Na, In Young
(Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine)
Chung, Eun Seon (Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine) Jung, Chang-Yun (Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine) Kim, Dae Hun (Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine) Shin, Juyoun (Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine) Kang, KyeongJin (Department of Anatomy and Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine) Kim, Seong-Tae (Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine) Ko, Kwan Soo (Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine) |
1 | Antunes LCS, Impeeri F, Carattoli A, Visca P. 2011. Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS ONE 6: e22674. DOI |
2 | Chuang YC, Sheng WH, Li SY, Lin YC, Wang JT, Chen YC, Chang SC. 2011. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia. Clin. Infect. Dis. 52: 352-360. DOI |
3 | Chusri S, Chongsuvivatwong V, Rivera JI, Slipapojakul K, Singkhamana K, McNeil E, Doi Y. 2014. Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii. Antimicrob. Agents Chemother. 58: 4172-4179. DOI |
4 | Clemmer KM, Bonomo RA, Rather PN. 2011. Genetic analysis of surface motility in Acinetobacter baumannii. Microbiology 157: 2534-2544. DOI |
5 | de Breij A, Dijkshoorn L, Lagendijk E, van der Meer J, Koster A, Bloemberg G, et al. 2010. Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii? PLoS One 5: e10732. DOI |
6 | Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5: 939-951. DOI |
7 | Foster TJ. 2005. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3: 948-958. DOI |
8 | Eijkelkamp BA, Stroeher UH, Hassan KA, Papadimitrious MS, Paulsen IT, Brown MH. 2011. Adherence and motility characteristics of clinical Acinetobacter baumannii isolates. FEMS Microbiol. Lett. 323: 44-51. DOI |
9 | Fishbain J, Peleg AY. 2010. Treatment of Acinetobacter infections. Clin. Infect. Dis. 51: 79-84. DOI |
10 | Fitzpatrick MA, Ozer E, Bolon MK, Hauser AR. 2015. Influence of ACB complex genospecies on clinical outcomes in a US hospital with high rates of multidrug resistance. J. Infect. 70: 144-152. DOI |
11 | Jefferson KK. 2004. What drives bacteria to produce a biofilm? FEMS Microbiol. Lett. 236: 163-173. DOI |
12 | Kim SW, Choi CH, Moon DC, Jin JS, Lee JH, Shin JH, et al. 2009. Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins. FEMS Microbiol. Lett. 301: 224-231. DOI |
13 | Ko KS, Suh JY, Kwon KT, Jung SI, Park KH, Kang CI, et al. 2007. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J. Antimicrob. Chemother. 60: 1163-1167. DOI |
14 | March C, Regueiro V, Llobet E, Moranta D, Morey P, Garmendia J, Bengoechea JA. 2010. Dissection of host cell signal transduction during Acinetobacter baumannii-triggered inflammatory response. PLoS One 5: e10033. DOI |
15 | Liao CH, Sheng WH, Chen YC, Hung CC, Wang JT, Chang SC. 2007. Predictive value of the serum bactericidal test for mortality in patients infected with multidrug-resistant Acinetobacter baumannii. J. Infect.55: 149-157. DOI |
16 | Lee HW, Koh YM, Kim J, Lee J, Lee YC, Seol SY, Cho DT. 2008. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin. Microbiol. Infect. 14: 49-54. DOI |
17 | Nemec A, Krizova L, Maixnerova M, Sedo O, Brisse S, Higgins PG. 2015. Acinetobacter seifertii sp. nov. a member of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated from human clinical specimens. Int. J. Syst. Evol. Microbiol. 65: 934-942. DOI |
18 | McConnell MJ, Actis L, Pachon J. 2013. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol. Rev. 37: 130-135. DOI |
19 | Mussi MA, Gaddy JA, Cabruja M, Arivett BA, Viale AM, Rasia R, Actis LA. 2010. The opportunistic human pathogen Acinetobacter baumannii senses and responds to light. J. Bacteriol. 192: 6226-6345. DOI |
20 | Park KH, Shin JH, Lee SY, Kim SH, Jang MO, Kang SJ, et al. 2013. The clinical characteristics, carbapenem resistance, and outcome of Acinetobacter baumannii bacteremia according to genospecies. PLoS One 8: e65026. DOI |
21 | Park YK, Choi JY, Jung SI, Park KH, Lee H, Jung DS, et al. 2009. Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals. Diagn. Microbiol. Infect. Dis. 64: 389-395. DOI |
22 | Rodriguez-Bano J, Marti S, Soto S, Fernandez-Cuenca F, Cisneros JM, Pachon J, et al. 2008. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin. Microbiol. Infect. 14: 276-278. DOI |
23 | Park YK, Jung SI, Park KH, Kim DH, Choi JY, Kim SH, Ko KS. 2012. Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.J. Med. Microbiol. 61: 71-79. DOI |
24 | Peleg AY, de Breij A, Adams MD, Cerqueira GM, Mocali S, Galardini M, et al. 2012. The success of Acinetobacter species; genetic, metabolic and virulence attributes. PLoS One7: e46984. DOI |
25 | Touchon M, Cury J, Yoon EJ, Krizova L, Cerqueira GC, Murphy C, et al. 2014. The genomic diversification of the whole Acinetobacter genus: origins, mechanisms, and consequences. Genome Biol. Evol. 6: 2866-2882. DOI |
26 | Seidi K, Goerke C, Wolz C, Mack D, Berger-Bachi B, Bischoff M. 2008. Staphylococcus aureus CcpA affects biofilm formation. Infect. Immun. 76: 2044-2050. DOI |
27 | Shamim S, Rehman A, Qazi MH. 2014. Swimming, swarming, twitching, and chemotactic responses of Culpriavidus metallidurans CH34 and Pseudomonas putida mt2 in the presence of cadmium. Arch. Environ. Contam. Toxicol. 66: 407-414. DOI |
28 | Towner KJ. 2009. Acinetobacter: an old friend, but a new enemy. J. Infect. 73: 355-363. |
29 | Wang J, Ruan Z, Feng Y, Fu Y, Jiang Y, Wang H, Yu Y. 2014. Species distribution of clinical Acinetobacter isolates revealed by different identification techniques. PLoS One 9: e104882. DOI |
![]() |